Home Search

parkinsons disease - search results

If you're not happy with the results, please do another search
Parkinson’s Disease, glowing green brain image

PKG (Personal Kinetigraph): Helping my Parkinson’s Disease patients

Parkinson’s Disease affects all activities of patient daily living but PKG can help.
Global Kinetics Limited - PKG

Global Kinetics – Parkinson’s disease management

Global Kinetics aim to improve the lives of those with Parkinson’s disease with advanced medical technologies.
Dupuytren’s disease

Research reveals that anti-TNF drug reverses Dupuytren’s disease

A clinical trial at Oxford University has found that a drug used for rheumatoid arthritis can reverse Dupuytren’s disease, if taken early on.
neurodegenerative disease, disease

JPND: Neurodegenerative disease research without boundaries

Jacqueline Hoogendam, JPND’s newly elected Vice-Chair and Executive Board member talks about JPND’s past and present strategies in its outreach campaign within and beyond Europe.
Death rate

Death rate from Parkinson’s disease rises in US

The death rate from Parkinson’s disease has risen by 63% in the United States, according to a new study.
symptom tracking, biomarkers

Novel digital biomarkers to aid in the diagnosis and tracking of symptoms in patients...

Dr Rutger Zietsma – CEO at Manus Neurodynamica Ltd – and PD Dr Angela Deutschländer share their vision on earlier diagnosis and objective symptom tracking with the NeuroMotor PenTM.
alzheimer’s and parkinson’s diseases

JPND: Enabling collaborative research in Alzheimer’s and Parkinson’s diseases

Professor of Neurology Thomas Gasser, JPND’s Scientific Advisory Board Chair and Director of the Department of Neurodegenerative Diseases, shares in an interview JPND’s innovative research and collaboration efforts in the universal race against Alzheimer’s and Parkinson’s diseases.
neurodegenerative diseases

New treatments for neurodegenerative diseases

Professor Dame Pamela Shaw explains how the National Institute for Health Research (NIHR) supports experimental medicine and translational research in neurodegenerative diseases.
parkinson's disease

New research may benefit patients with early stage Parkinson’s disease

A new study published in the Movement Disorders journal, has paved the way for more research into identifying markers of progression for patients in the early stages of Parkinson’s disease
brain disease test

National Institutes of Health scientists adapt new brain disease test for Parkinson’s

National Institutes of Health scientists develop new brain disease test for the early diagnosis of Parkinson’s disease and dementia with Lewy bodies The group, led by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), tested 60 cerebral spinal fluid samples, including 12 from people with Parkinson’s disease, 17 from...

Parkinson’s disease: are conventional treatments working?

Ramón Cacabelos, President of EuroEspes Biomedical Research Centre looks at conventional pharmacological treatments for Parkinson’s disease
parkinson's disease

Restoring dopaminergic nerve cells in Parkinson’s disease

Dr Mehis Pilv, CEO and business development lead at Genecode, discusses the strides being made in Parkinson's disease research Parkinson's disease is a slow but progressive neurodegenerative disorder. About 1% of people aged above 50 are affected worldwide. In Europe alone 1.2 million people suffer from Parkinson's disease, 127,000 of whom...

Brain disorders and the burden of diseases

Frédéric Destrebecq, Executive Director, and Vinciane Quoidbach, Public Health and Policy Project Manager at the European Brain Council, explain the socio-economic impact of interventions and the importance of early diagnosis with regard to brain disorders… Depression, stroke, dementia, alcohol dependence, schizophrenia or anxiety will affect at least one in three...
europe, brain health

JPND: Towards a stronger brain health partnership

One of JPND’s key objectives is to fortify its work in brain health partnerships in Europe to better combat the challenges of neurodegenerative disease (ND).
non-invasive brain surgery

FDA approves new non-invasive brain surgery for Parkinson’s symptoms

Research shows that a new form of non-invasive brain surgery using a focused form of ultrasound will prove invaluable for with Parkinson’s symptoms.
Patients and Public Involvement

Patient and Public Involvement at the heart of brain research

Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
auditory development

The importance of patterned activity in the nervous system for auditory functions

George Ordiway, a PhD student in the laboratory of Dr. Jason Tait Sanchez at Northwestern University, discusses how patterned activity in the nervous system permits a wide range of biologically relevant functions, including auditory development.
future of europe, role of chemistry

Chemistry for the future of Europe

Alex Schiphorst, Science Communication and Policy Officer discusses the vital role of chemistry when it comes to the future of Europe.
neurodegenerative disorders

Early diagnosis of neurodegenerative disorders: Where are we now?

Dr Gerry Morrow shares his thoughts on the current state of play when it comes to the early diagnosis of neurodegenerative disorders, and asks the questions, can we screen, and should we screen?
therapeutic intervention

What’s in an aggregate? Therapeutic intervention in Huntington’s

Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention

Follow Open Access Government